LOS ANGELES--(BUSINESS WIRE)--
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Natus Medical, Inc. (“Natus” or “the Company”) (NASDAQ: BABY) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. GlassHouse Research published a report about Natus on February 6, 2019, entitled, “Throw the BABY (Natus Medical Inc.) Out with the Bathwater.” The report accused the Company of deceptive accounting practices. Based on this report, shares of Natus fell by more than 4% on the same day. Natus then announced on May 6, 2019, that it would restate its financial results for the quarter ending March 31, 2019. The Company disclosed that the restatement was necessary because “the Company identified non-cash currency translation adjustments and related tax effects that should have been accounted for in connection with the impairment charge for the divestiture of Medix.” Based on this news, Natus fell in after-hours trading.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at firstname.lastname@example.org.
The class in this case has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.